Neonatal jaundice affects up to 85% of full-term newborns and remains one of the most common health challenges in early life. Traditional hospital-based monitoring methods are often complex,expensive, and inaccessible for home use or grassroots clinics.

Bilimonitor redefines jaundice management with a clinically validated, non-invasive, and easy-to-use solution for both parents and healthcare providers. It enables at-home, clinical -grade monitoring andsupports reliable screening in primary care settings.

Since launch, Bilimonitor has supported the healthy growth of over 250,000 newborns and formed strong partnerships with 200+ hospitals. Its consumer version has achieved over 200,000 units sold across leading platforms like JD.com, earning widespread trust and continued market momentum.

With FDA Class II clearance and Southeast Asia registrations in progress, Bilimonitor is accelerating its global rollout to meet growing demand for safer, more accessible jaundice care solutions

Bilimonitor BJM-20Jaundice Meter

Leveraging proprietary optoelectronic technology, we have redefined neonatal jaundice screening—achieving unprecedented accuracy and cost-efficiency.

Medical-grade jaundice monitor, specifically optimized for home use. Enables convenient and continuous at-home monitoring while supporting remote doctor-patient follow-up, creating an efficient bridge home and clinic.